Omics Sequencing of Exosomes in Body Fluids of Patients With Acute Lung Injury
NCT05058768 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2022-05-10
Summary
The exosomes in the experimental group and the control group were sequenced to find the difference of the two groups, providing a basis for subsequent basic research.
Conditions
- Acute Lung Injury
Interventions
- DIAGNOSTIC_TEST
-
The lungs causes and extrapulmonary factors
Acute lung injury due to internal and external pulmonary causes can be used as intervention items in this study, and intervention items can be excluded according to inclusion criteria and exclusion criteria.
Sponsors & Collaborators
-
Nanfang Hospital, Southern Medical University
lead OTHER
Principal Investigators
-
linzhong yu, professor · Nanfang Hospital, Southern Medical University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-06
- Primary Completion
- 2023-05-07
- Completion
- 2024-12-16
Countries
- China
Study Locations
More Related Trials
-
The Role of Circulating CircRNAs and MicroRNAs in Acute Lung Injury
NCT03766204 ·Status: UNKNOWN
-
Risk Stratification of COVID-19 Using Urine Biomarkers
NCT04681040 ·Status: ACTIVE_NOT_RECRUITING
-
The Role and Mechanism of O-GlcNAc Glycosylation Modified HAS2 in the Hyaluronic Acid Synthesis in ARDS
NCT05055557 ·Status: UNKNOWN
-
Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study
NCT07289711 ·Status: RECRUITING
-
Change of Immune Cell of ARDS Patients:an Observational Study
NCT02958748 ·Status: UNKNOWN
-
Study of the Effects of Bronchoalveolar Lavage Liquid in the ARDS on the Functioning of the Neutrophil Polynuclear System
NCT04008225 ·Status: COMPLETED
-
Detection of Pathogen and Antibiotic Resistance Genes by Targeted Next-Generation Sequencing in ICU Patients.
NCT06157372 ·Status: NOT_YET_RECRUITING
-
Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS
NCT05933291 ·Status: COMPLETED
-
Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)
NCT04552821 ·Status: UNKNOWN
-
The Value of Serum MicroRNA-21-5p and LncRNAgadd7 Expression Levels in Predicting the Severity and Prognosis of ARDS ( Acute Respiratory Distress Syndrome )
NCT06825754 ·Status: COMPLETED
-
Clinical Features, Treatments, and Outcomes in Acute Respiratory Distress Syndrome (ARDS-CTO)
NCT07186140 ·Status: NOT_YET_RECRUITING
-
Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support
NCT01967602 ·Status: UNKNOWN
-
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
NCT05357170 ·Status: RECRUITING
-
Discovery of New Early Detection Biomarkers From Peripheral Blood of Acute Respiratory Distress Syndrome(ARDS)
NCT02967471 ·Status: UNKNOWN
-
Biological Markers to Identify Early Sepsis and Acute Lung Injury
NCT00825357 ·Status: COMPLETED
-
Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome
NCT03641690 ·Status: COMPLETED
-
An Observational Study of the Correlation Between miRNA in Peripheral Blood and Prognosis in Patients With ARDS
NCT02885675 ·Status: UNKNOWN
-
Measuring Auto-fluorescence of White Corpuscles for the Early Diagnosis and the Monitoring of Pneumonia in ICU
NCT02717767 ·Status: COMPLETED
-
Serial Changes of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Levels in Patients With Acute Respiratory Distress Syndrome
NCT00557414 ·Status: COMPLETED
-
Validation of the Accuracy of a Novel POCT Dry Blood Gas Analyzer in Acute Care Settings
NCT06726473 ·Status: COMPLETED
-
Explore Potential Plasma and BALF Immunometabolic and Lipidomic Biomarkers for Identifying ARDS Endotypes
NCT05451342 ·Status: UNKNOWN
-
Influence of Acute Respiratory Distress Syndrome (ARDS) and Severe Sepsis on sRAGE Levels in ICU Patients
NCT00811629 ·Status: COMPLETED
-
Discovery of New Early Detection Biomarkers of Acute Respiratory Distress Syndrome
NCT02625064 ·Status: UNKNOWN
-
Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials
NCT00719446 ·Status: COMPLETED
-
Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS
NCT04452097 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2